GROWTH LIMITATION IN HYBRIDOMA CELL-CULTURES - THE ROLE OF INHIBITORY OR TOXIC METABOLITES

被引:17
作者
RONNING, OW
SCHARTUM, M
WINSNES, A
LINDBERG, G
机构
[1] Center for Industrial Research (SI), Oslo 3, 0314, Blindern
[2] Apothekernes Laboratorium A.S., Oslo 2, 0212, Skøyen
关键词
HYBRIDOMA CELLS; INHIBITORY OR TOXIC METABOLITES; GROWTH MEDIUM; GEL FILTRATION;
D O I
10.1007/BF00135634
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Hybridoma cells usually grow to fairly low cell densities in batch cultures (1-3 x 10(6) cells/ml). The reason for this is either that essential nutritional components of the medium are consumed, or that the cells produce some kind of inhibitory or toxic metabolite. This investigation presents evidence for the latter. Spent medium from cultures of hybridoma cells did not support growth of cells at lower cell densities (1-3 x 10(5) cells/ml). The ability to support cell growth could not be restored by adding additional serum, energy sources (glucose, pyruvate) or L-glutamine. Furthermore, the consumption of amino acids could not account for this growth inhibition. On the contrary, the spent medium contained a substance that inhibited cell growth. This substance or metabolite was found in a fraction eluted from a gel filtration column when spent medium was applied to the column. This substance was found in the spent medium from all hybridoma and myeloma cell lines that were tested. The molecular weight of the substance was about 5 kD. Spent medium from two hybridoma cell lines also contained a substance that was eluted in the same fraction as albumin (67 kD). It is likely that this (or these) substance(s) is responsible for the growth limitation in hybridoma cell cultures.
引用
收藏
页码:15 / 24
页数:10
相关论文
共 12 条
[1]  
Butler M., Jenkins H., Nutritional aspects of the growth of animal cells in culture, J. Biotechnol, 12, pp. 97-110, (1989)
[2]  
Caroll W.L., Thielemans K., Dilley J., Levy R., Mouse x human heterohybridomas as fusion partners with human B cell tumors, J. Immunol. Methods, 89, pp. 61-72, (1986)
[3]  
Comer M.J., Kearns M.J., Wahl J., Munster M., Lorenz T., Szperalski B., Koch S., Behrendt U., Brunner H., Industrial production of monoclonal antibodies and therapeutic proteins by dialysis fermentation, Cytotechnology, 3, pp. 295-299, (1990)
[4]  
Glacken M.W., Fleischaker R.J., Sinskey A.J., Reduction of waste product excretion via nutrient control: Possible strategies for maximizing product and cell yields on serum in cultures of mammalian cells, Biotechnol. Bioeng., 27, pp. 1376-1389, (1986)
[5]  
Handa-Corrigan A., Large scale in vitro hybridoma culture: Current status, Biotechnology, 6, pp. 784-786, (1988)
[6]  
Kidwell W.R., Filtering out inhibition, Bio/Technology, 7, pp. 462-463, (1989)
[7]  
Kvalhein G., Fodstad O, Phil A., Nustad K., Pharo A., Ugelstad J., Funderud S., Elimination of B-lymphoma cells from human bone marrow: Model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies, Cancer res., 47, pp. 846-851, (1987)
[8]  
Lund A., Hellemann A.L., Vartdal F., Rapid isolation of K88+ Escherichia coli by using immunomagnetic particles, J. Clin. Microbiol., 26, pp. 2572-2575, (1988)
[9]  
Mosmann T., Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, J. Immunol Methods, 65, pp. 55-63, (1983)
[10]  
Newland M., Greenfield P.F., Reid S., Hybridoma growth limitations: The role of energy metabolism and ammonia production, Cytotechnology, 3, pp. 215-229, (1990)